Visio-postpartum a2 gd 6-10-08.vsd

Postpartum Ward
Safe in Breastfeeding5
Postpartum A2 Gestational Diabetes References:
Kim C, Herman WH, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among
women with histories of gestational diabetes mellitus. Diabetes Care 2007; 30:1102. In a cost
analysis, screening women with a history of GDM with an oral glucose tolerance test every three
years resulted in the lowest cost per case of diabetes diagnosed. Q2 year fasting plasma glucose
or Q3 year oral glucose tolerance testing result in equivalent cost per person screened and
equivalent duration of undiagnosed diabetes.

Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-
Conference on Gestational Diabetes Mellitus: the organizing committee. Diabetes Care 1998; 21
(Suppl. 2) 161-167.
Women with gestational diabetes should undergo glucose tolerance testing at
least 6 weeks post partum and should be reassessed at a minimum of
Q3 year intervals.
Gunderson EP. Breastfeeding after gestational diabetes pregnancy: subsequent obesity and type 2
diabetes in women and their offspring. Diabetes Care 2007; 30 (Suppl. 2) S161 – S168. Breastfeeding
has beneficial effects for mom (decreased glucose intolerance and increased weight loss) and may
decrease offspring risk for obesity in childhood and adolescence.

Schaefer-Graf UM, Hartmann R, Pauliczak J, Passow D, Abou-Dakn M. Association of breast- feeding
and early childhood overweight in children from mothers with GDM. Diabetes Care 2006; 29:5. Study
of 324 offspring of mothers with GDM had childhood overweight prevalence of 37.3% if not breastfed,
32.5% if breastfed for up tot 3 mos., and 22% if breastfed for over 3 mos. (P=0.008)

Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF. Transfer of metformin into human milk.
Diabetologia 2002; 45: 1509-1514. Seven women with healthy infants taking a median dose of
1500mg Metformin were studied with low concentrations of Metformin seen in breast milk. Mean infant
exposure was only 0.28% of the weight normalized maternal dose, and absolute infant dose average of

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care
2004; 27: (Suppl. 1)
. A fasting plasma glucose >126 or a casual plasma glucose >200 meets the
threshold for diagnosis of diabetes if confirmed on subsequent day. Confirmation precludes the need for
glucose challenge. Fasting plasma glucose 100 – 125 (impaired fasting glucose or “prediabetes”)
indicates significant high risk for developing diabetes as well as other cardiovascular risk. Intervention
can prevent or delay development of diabetes. Either glucose tolerance testing (2hr) or fasting glucose
testing can be performed.

Nathan DM, Davidson MB, DeFronzo RA. Impaired fasting glucose and impaired glucose
tolerance: implications for care. Diabetes Care 2007; 30:753. Fasting plasma glucose 100 –125
(impaired fasting glucose or “prediabetes”) indicates significant high risk for developing diabetes as well
as other cardiovascular risk. Intervention can prevent or delay development of diabetes.

These algorithms are designed to assist the primary care provider in the clinical management of a variety of problems that occur in pregnancy. They should not be interpreted as standard of care but instead represent guidelines for the management of these patients. Variation in practice should be taken into account such factors as characteristics of the individual patient, health resources, and regional experience with diagnostic and therapeutic modalities. The algorithms remain the intellectual property of the University of North Carolina School of Medicine at Chapel Hill. They cannot be reproduced in whole or part without the expressed permission of the school.
Copyright May 2008 UNC School of Medicine at Chapel Hill


E-mail -morning news do

D I E W E R T PA P I E R H A N D E L S B A N K Morning News 13. Juni 2013 Differenz Differenz Differenz US Börsen Overnight: Die Angst vor einem Ende des billigen Geldes drängt gegenwärtig auch an den US Börsen alles andere in den Hintergrund. Eine Mini-Erholung zum Handelsstart hielt am Mittwoch nicht lange, der Dow-Jones-Index schloss erstmals seit dem 5. Juni wie

A survey of the utilization of antipseudomonal betalactam therapy in cystic fibrosis patients

Pediatric Pulmonology 46:987–990 (2011)A Survey of the Utilization of Anti-PseudomonalBeta-Lactam Therapy in Cystic Fibrosis PatientsJeffery T. Zobell, PharmD,1,2* David C. Young, PharmD,3 C. Dustin Waters, PharmD, BCPS,4Krow Ampofo, MD,5 Jared Cash, PharmD, BCPS,1 Bruce C. Marshall, MD,6Summary. The purpose of this study was to characterize the utilization of anti-pseudomonalbeta-lactam an

Copyright ©2010-2018 Medical Science